Engineers Gate Manager LP Editas Medicine, Inc. Transaction History

Engineers Gate Manager LP

$3.68 Billion
Q1 2024

A detailed history of Engineers Gate Manager LP transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 87,989 shares of EDIT stock, worth $399,470. This represents 0.02% of its overall portfolio holdings.

Number of Shares

87,989

Previous 91,580 3.92%

Holding current value

$399,470

Previous $927,000 29.67%

% of portfolio

0.02%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$7.03 - $11.07 $25,244 - $39,752	-3,591 Reduced 3.92%	87,989 $652,000
Q4 2023 Feb 14, 2024	BUY	$6.25 - $11.11 $211,462 - $375,895	33,834 Added 58.59%	91,580 $927,000
Q3 2023 Nov 14, 2023	SELL	$6.92 - $9.31 $198,846 - $267,522	-28,735 Reduced 33.23%	57,746 $450,000
Q2 2023 Aug 14, 2023	BUY	$6.36 - $11.47 $550,019 - $991,937	86,481 New	86,481 $711,000
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $179,250 - $286,270	14,741 Added 52.16%	43,002 $526,000

Q2 2022 Aug 15, 2022	BUY	$9.99 - $21.35 $17,112 - $36,572	1,713 Added 6.45%	28,261 $334,000
Q1 2022 May 16, 2022	BUY	$14.08 - $27.63 $144,672 - $283,898	10,275 Added 63.14%	26,548 $505,000
Q4 2021 Feb 14, 2022	SELL	$26.55 - $40.57 $222,940 - $340,666	-8,397 Reduced 34.04%	16,273 $432,000
Q3 2021 Nov 15, 2021	BUY	$39.27 - $72.94 $968,790 - $1.8 Million	24,670 New	24,670 $1.01 Million
Q2 2021 Aug 16, 2021	SELL	$31.29 - $56.64 $621,419 - $1.12 Million	-19,860 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$39.71 - $90.58 $788,640 - $1.8 Million	19,860 New	19,860 $834,000
Q4 2020 Feb 16, 2021	SELL	$27.07 - $84.35 $474,916 - $1.48 Million	-17,544 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$28.06 - $37.16 $76,772 - $101,669	2,736 Added 18.48%	17,544 $492,000
Q2 2020 Aug 17, 2020	BUY	$18.5 - $34.34 $6,031 - $11,194	326 Added 2.25%	14,808 $438,000
Q1 2020 May 15, 2020	SELL	$14.88 - $32.78 $85,083 - $187,436	-5,718 Reduced 28.31%	14,482 $287,000
Q4 2019 Feb 14, 2020	BUY	$19.49 - $32.63 $174,942 - $292,886	8,976 Added 79.97%	20,200 $598,000
Q3 2019 Nov 14, 2019	BUY	$22.49 - $26.81 $252,427 - $300,915	11,224 New	11,224 $255,000

Others Institutions Holding EDIT

# of Institutions

243

Shares Held

69.3M

Call Options Held

564K

Put Options Held

428K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $312M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Editas Medicine, Inc. Transaction History